Evidax generates comparative evidence for your asset when head-to-head data are limited.
Your pivotal trial may be single-arm. Or it may be randomised, but not against the treatments patients actually receive in the market you want to enter.
That leaves HTA bodies, payers and clinicians asking important questions your trial was never designed to answer.
Evidax maps the evidence you have against the evidence that stakeholders need to make decisions, identifies exactly what is missing, and generates the evidence to close those gaps. We combine your existing clinical data with published and real-world evidence to build the comparative evidence needed for reimbursement, adoption and market access.
We do this with rigour and speed, combining methodological expertise with purpose-built workflows to deliver decision-ready evidence in weeks, not months.